spec sheet12 rows
Nitric oxide (NO) is a colorless gas and free radical that serves as one of the body's most important signaling molecules. Produced naturally in blood vessels, nerves, and immune cells, it relaxes vascular smooth muscle to widen blood vessels and increase blood flow, and it also participates in neurotransmission and host defense. Its identification as the endothelium-derived relaxing factor earned Robert Furchgott, Louis Ignarro, and Ferid Murad the 1998 Nobel Prize in Physiology or Medicine. In medicine, nitric oxide is delivered as an inhaled gas to relax the lung's blood vessels in newborns with pulmonary hypertension.
- a Nobel winning signalling molecule behind healthy blood flow
- nasal spray cuts viral load right where infection starts
- speeds clearance of SARS-CoV-2 in the nose
- broad antimicrobial coverage, not tied to one virus
- cheap and simple to reach for at the first sniffle
- well tolerated over the short courses on the label
- As a concentrated gas it is a respiratory irritant that can injure the airways at high environmental levels
- When inhaled as a medicine it can convert some hemoglobin to methemoglobin, reducing oxygen carriage
- In oxygen-rich gas it can be oxidized to nitrogen dioxide, a more toxic lung irritant
Overview
Nitric oxide is a small diatomic molecule with the formula NO, a colorless gas that is also a free radical because it carries an unpaired electron [1]. It should not be confused with nitrous oxide (N2O), the anesthetic gas, or nitrogen dioxide (NO2), an air pollutant. In biology its most striking properties are that it is highly reactive and short-lived, surviving only seconds, yet it slips freely across cell membranes, which makes it well suited to act as a local, fast-acting messenger between neighboring cells [1][2].
Although NO was long regarded merely as a toxic component of smog and combustion, its biological significance emerged in the 1980s when investigators realized that the elusive endothelium-derived relaxing factor, a substance released by the lining of blood vessels to relax them, was in fact nitric oxide [1]. This discovery reshaped cardiovascular physiology and led to the 1998 Nobel Prize in Physiology or Medicine being awarded to Robert Furchgott, Louis Ignarro, and Ferid Murad; the molecule was also named Molecule of the Year in 1992.
In the body NO is generated mainly by a family of enzymes called nitric oxide synthases, which convert the amino acid L-arginine, together with oxygen and the cofactor NADPH, into nitric oxide [2]. A separate, complementary route allows inorganic nitrate and nitrite, including nitrate obtained from the diet in vegetables such as leafy greens and beets, to be recycled back into NO, a pathway that becomes especially important when oxygen is scarce [3].
Physiologically, nitric oxide is a central regulator of vascular tone, prompting the smooth muscle around arteries to relax so that vessels dilate and blood flow rises [1][2]. A healthy endothelium continuously produces NO, and a reduced capacity to make or respond to it, termed endothelial dysfunction, is a hallmark of conditions such as hypertension and atherosclerosis [1]. The molecule also acts as a neurotransmitter in the nervous system and as a weapon of the immune system against pathogens. The erectile-dysfunction drug sildenafil works by amplifying the signaling that lies downstream of nitric oxide rather than by supplying NO itself [1].
As a medicine, nitric oxide is given directly as an inhaled gas. Its best-established use is in persistent pulmonary hypertension of the newborn, a dangerous failure of the circulation to adapt after birth, where inhaled NO selectively relaxes the lung's blood vessels and improves oxygenation [4]. Because concentrated nitric oxide is a respiratory irritant and can be oxidized to more toxic nitrogen oxides, its industrial handling and its clinical delivery are both carefully controlled [1].
- Science magazine named nitric oxide its Molecule of the Year in 1992, six years before the Nobel Prize that honored its discovery.
- The same molecule underlies the action of nitroglycerin, used for angina for a century before its biology was understood.
- Its biological half-life is only a few seconds, which is why inhaled nitric oxide acts almost entirely within the lung.
Mechanism
exerts most of its classic effects through a signaling cascade that begins when it is produced by endothelial nitric oxide synthase from L-arginine in the lining of blood vessels [2]. Once formed, NO diffuses into the neighboring smooth muscle cells, where its principal molecular target is the enzyme soluble guanylyl cyclase [2]. Activating this enzyme raises the level of the second messenger cyclic guanosine monophosphate (cGMP), which in turn lowers intracellular calcium and relaxes the muscle, producing and increased blood flow [2].
can also act through cGMP-independent routes, notably by attaching to reactive thiol groups on proteins in a process called S-nitrosylation, which modifies their function [2]. When enzymatic production falls short, particularly under low-oxygen conditions, the body can regenerate NO from circulating nitrite and dietary nitrate, providing a backup source of the molecule [3]. In the lungs, delivering as an inhaled gas exploits the same guanylyl cyclase pathway to relax pulmonary blood vessels while its brief lifespan largely confines the effect to the lung, sparing the rest of the circulation [4].
receptor fingerprint
SARS-CoV-2 virions and viral proteinsinhibits
Viral replication enzymesinhibits
Nasal mucosal surfacemodulates
Soluble guanylate cyclase (cGMP)activates
Broad bacterial and viral pathogensinhibits
Spike protein and ACE2 interactionblocks
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
The nasal spray is sold over the counter or as a medical device in the countries where it is approved, and it is generally well tolerated. The most common complaints are local; a brief stinging or burning in the nose, sneezing, a runny or dry nose, and mild headache. It is meant for short-term use at the first signs of infection or after exposure, following the label. One thing worth separating out is that inhaled nitric oxide gas, used in hospitals for newborns and pulmonary hypertension, is a different, tightly regulated product that can cause methemoglobinemia and rebound effects; the nasal spray delivers far smaller, localized amounts. As with any new product, people who are pregnant or managing a medical condition should check with a clinician first.
Interactionsdocumented pairs only, not exhaustive
Nitric oxide is absolutely contraindicated with phosphodiesterase-5 (PDE5) inhibitors such as sildenafil, tadalafil, and vardenafil. The combination of a nitric oxide donor through pharmaceuticals or nitrate therapy with any PDE5 inhibitor produces an additive vasodilatory effect that can cause severe, potentially life-threatening hypotension; mean systolic blood pressure reductions of 23 to 36 mm Hg have been documented in clinical trials, with some patients dropping below 85 mm Hg [7].
This interaction is driven by both agents converging on the same cGMP-mediated vasodilation pathway; PDE5 inhibitors prevent the breakdown of cGMP generated by nitric oxide, amplifying the effect [8]. Because of this risk, any patient taking chronic or episodic nitrate therapy must avoid PDE5 inhibitors entirely, and the reverse is also true; clinicians should counsel patients on the absolute nature of this contraindication.
Checking a whole stack? Run it through interactions + stacks.
History
The biological importance of nitric oxide was established in the 1980s, when Robert Furchgott, Louis Ignarro, and Ferid Murad independently demonstrated that the elusive endothelium-derived relaxing factor was in fact this simple gaseous free radical; work later recognized with the 1998 Nobel Prize in Physiology or Medicine. The journal Science named nitric oxide its Molecule of the Year in 1992, well before that Nobel.
Inhaled nitric oxide entered clinical medicine at the end of the decade, gaining United States approval in 1999 to relax the lung's blood vessels in newborns with persistent pulmonary hypertension. More recently, companies including SaNOtize developed nitric oxide-releasing nasal sprays, marketed as Enovid and VirX and studied under the name NONS, as topical antimicrobial and antiviral products. These sprays were tested in randomized trials during the COVID-19 pandemic as a means of accelerating clearance of the virus from the nose.
Reputation
Few molecules command as much scientific respect as nitric oxide; its recognition as a fundamental signaling messenger reshaped physiology and earned a Nobel Prize. In medicine, inhaled nitric oxide is a genuinely life-saving therapy for newborns with pulmonary hypertension, and its natural roles in blood flow, immunity, and neurotransmission are extensively documented. The newer nitric oxide nasal sprays have generated real excitement as a simple, topical way to blunt respiratory infection, with randomized trials reporting faster clearance of SARS-CoV-2 from the nasal passages. In fairness, the magnitude of that clinical benefit has been modest and debated, and the sprays are best understood as an adjunct rather than a cure. As a foundational biological molecule with a steadily expanding therapeutic toolkit, however, nitric oxide's standing is secure.
Subjective profileweighing the evidence above
The nasal spray is a reasonable, low-cost thing to reach for at the first sign of a cold; there is real data on cutting viral load right at the site of entry, and short-term use is well tolerated. Keep it short and follow the label. The inhaled medical gas is a different thing entirely, with airway irritation and methemoglobin risk.
Where to buy
Suppliers
Vendors carrying Nitric Oxide, with live product details and codes. Links are affiliate links that support the wiki at no cost to you.
PCT.Zone
Nitric Oxide
Research
- 2003first citedCardiovascular effects of tadalafil.
- 2022most recentSARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A ran…
- 1.Nitric Oxide and Endothelial Dysfunction.
- 2.Vascular nitric oxide: Beyond eNOS.
- 3.The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.
- 4.Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.
- 5.SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial
- 6.Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection
- 7.Cardiovascular effects of tadalafil.
- 8.Sexual function in hypertensive patients receiving treatment.
8 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
When should I use nitric oxide nasal spray?
It is designed for early use, at the first sign of symptoms or soon after a known exposure, since it works by cutting virus in the nose before infection takes hold.
Does it replace vaccines or treatment?
No. It is a supportive measure meant to lower viral load locally, not a substitute for vaccination or prescribed antiviral drugs for higher-risk illness.
Is it the same as inhaled nitric oxide in hospitals?
No. Hospital inhaled NO gas is a separate, tightly regulated therapy for the lungs. The nasal spray delivers small, localized amounts to the nose and is a different product.
How often can I use it?
Labels typically allow several uses a day for a short stretch. Follow the specific product instructions and do not exceed the stated frequency.
Does the evidence support it?
A randomized trial found it sped up nasal clearance of SARS-CoV-2, and several countries granted approval, but the overall evidence is still moderate and evolving.
Adverse effects
- As a concentrated gas it is a respiratory irritant that can injure the airways at high environmental levels
- When inhaled as a medicine it can convert some hemoglobin to methemoglobin, reducing oxygen carriage
- In oxygen-rich gas it can be oxidized to nitrogen dioxide, a more toxic lung irritant
- Abruptly stopping inhaled nitric oxide can trigger a rebound rise in pulmonary blood pressure
Notes and cautions
- Clinical use is monitored and reserved for supervised hospital settings
